SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bradpalm1 who wrote (2899)3/21/1998 1:25:00 PM
From: Hank  Read Replies (1) of 7041
 
Yes, Viagra will undoubtedly be in very high demand once it hits the market. One of the things that every drug company strives for is being first to market with a hot new drug. The greater the head start, the bigger their potential market share since patients tend to stay on what works for them rather than switching around to try every new product that comes to market. If SGP truly believes that Vasomax is good enough to be approved in the US, then they'd better get rolling and submit an NDA soon. The longer they wait, the less likely they'll be able to take significant market share away from Viagra IF Vasomax ever gets approved.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext